Pancreatic cancer is one of the most serious malignancies and the prognosis of those who develop it is usually extremely poor. This is what motivates scientists to keep looking for new treatment options for this condition. Interesting reports are presented by specialists from theUniversity of Texas MD Anderson Cancer Center in Houston, who report that therapeutic interactions targeting a protein produced by pancreatic cancer stromal tissue may improve patient pro gnosis.